The management of pancreatic neuroendocrine tumors (PanNETs) involves classification
into non-functional or functional PanNET, and as localized or metastatic PanNET. In …

Purpose To assess the ability of radiomic features (RF) extracted from contrast-enhanced CT
images (ceCT) and non-contrast-enhanced (non-ceCT) in discriminating histopathologic …

There is a recent update in WHO classification of pancreatic neuroendocrine neoplasms
(PanNENs). Our aim is to analyse the latest management for patients with PanNENs …

Simple Summary Pancreatic ductal adenocarcinoma is a devastating illness but guidelines
consider it unresectable once metastasized. However, resection of the primary tumor is …

Pancreatic neuroendocrine tumors (PNETs) arise from endocrine pancreatic cells and
comprise 3-5% of pancreatic cancers. Surgical resection is the only potentially curative …

BACKGROUND Liver metastasis (LM) remains a major cause of cancer-related death in
patients with pancreatic cancer (PC) and is associated with a poor prognosis. Therefore …

Introduction: Cancer-associated fibroblasts (CAF) have been identified as relevant
contributors to cancer progression and drug resistance in many tumors. Although …

Neuroendocrine neoplasms (NENs) are relatively rare neoplasms occurring predominantly
in the gastrointestinal tract and pancreas. Their heterogeneity poses challenges for …

Purpose NETTER-R aimed to determine the efficacy, safety and tolerability of 177Lu-
DOTATATE in patients with progressive, advanced pancreatic neuroendocrine tumours …

Pancreatic neuroendocrine neoplasms (panNEN) are a heterogeneous group of tumors with
differing pathological, genetic, and clinical features. Based on clinical findings, they may be …